The Journal of Pediatrics
Volume 157, Issue 2 , Pages 179-180 , August 2010

Congenital Cytomegalovirus Infection: Screening and Treatment

References 

  1. Kharrazi M, Hyde T, Young S, Amin MM, Cannon MJ, Dollard SC. Use of screening dried blood spots for estimation of prevalence, risk factors, and birth outcomes of congenital cytomegalovirus infection. J Pediatr. 2010;157:191–197
  2. Shoji K, Ito N, Ito Y, Inoue N, Adachi S, Fujimaru T, et al. Is a six-week course of ganciclovir therapy enough for chorioretinitis in an infant with congenital cytomegalovirus infection?. J Pediatr. 2010;157:331–333
  3. Oliver SE, Cloud GA, Sanchez PJ, Demmler GJ, Dankner W, Shelton M, et al. Neurodevelopmental outcomes following ganciclovir therapy in symptomatic congenital cytomegalovirus infections involving the central nervous system. J Clin Virol. 2009;46S:S22-S6
  4. Kimberlin DW, Lin CY, Sanchez PJ, Demmler GJ, Dankner W, Shelton M, et al. Effect of ganciclovir therapy on hearing in symptomatic congenital cytomegalovirus disease involving the central nervous system: a randomized, controlled trial. J Pediatr. 2003;143:16–25
  5. Guris D, Jumaan AO, Mascola L, Watson BM, Zhang JX, Chaves SS, et al. Changing varicella epidemiology in active surveillance sites - United States, 1995-2005. J Infect Dis. 2008;197:S71–S75
  6. Barbi M, Binda S, Caroppo S. Diagnosis of congenital CMV infection via dried blood spots. Rev Med Virol. 2006;16:385–392
  7. Dollard SC, Grosse SD, Ross DS. New estimates of the prevalence of neurological and sensory sequelae and mortality associated with congenital cytomegalovirus infection. Rev Med Virol. 2007;17:355–363
  8. Kimberlin DW, Acosta EP, Sanchez PJ, Sood S, Agrawal V, Homans J, et al. Pharmacokinetic and pharmacodynamic assessment of oral valganciclovir in the treatment of symptomatic congenital cytomegalovirus disease. J Infect Dis. 2008;197:836–845

 Supported by Virology Branch, Division of Microbiology and Infectious Diseases, NIAID, U01-AI063565. R.P. has received research support from Sanofi Pasteur and is a consultant to Merck

PII: S0022-3476(10)00345-8

doi: 10.1016/j.jpeds.2010.04.045

The Journal of Pediatrics
Volume 157, Issue 2 , Pages 179-180 , August 2010

Article Tools